PDPN and breast cancer: In the murine 4T1 breast cancer model, immunofluorescence co-staining with the lymphatic-specific marker podoplanin (PDPN) and FAT1 revealed a significant reduction in FAT1 fluorescence intensity within tumor-associated lymphatic vessels compared to those in normal mammary tissue (Figures 6A,C).